WallStSmart

Arthur J Gallagher & Co (AJG)vsEthos Technologies Inc. Class A Common Stock (LIFE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Arthur J Gallagher & Co generates 2476% more annual revenue ($15.11B vs $586.53M). AJG leads profitability with a 10.4% profit margin vs -18.1%. AJG earns a higher WallStSmart Score of 62/100 (C+).

AJG

Buy

62

out of 100

Grade: C+

Growth: 6.7Profit: 5.5Value: 5.7Quality: 5.5
Piotroski: 4/9Altman Z: 0.76

LIFE

Avoid

33

out of 100

Grade: F

Growth: 7.3Profit: 3.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 1.29

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AJG5 strengths · Avg: 9.0/10
Revenue GrowthGrowth
30.9%10/10

Revenue surging 30.9% year-over-year

Debt/EquityHealth
0.0910/10

Conservative balance sheet, low leverage

Market CapQuality
$61.60B9/10

Large-cap with strong market position

PEG RatioValuation
0.728/10

Growing faster than its price suggests

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

LIFE2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
113.4%10/10

Revenue surging 113.4% year-over-year

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Areas to Watch

AJG4 concerns · Avg: 2.8/10
P/E RatioValuation
39.9x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
6.6%3/10

ROE of 6.6% — below average capital efficiency

EPS GrowthGrowth
-10.7%2/10

Earnings declined 10.7%

Free Cash FlowQuality
$-41.00M2/10

Negative free cash flow — burning cash

LIFE4 concerns · Avg: 1.8/10
Return on EquityProfitability
-24.4%2/10

ROE of -24.4% — below average capital efficiency

EPS GrowthGrowth
-5.3%2/10

Earnings declined 5.3%

Altman Z-ScoreHealth
1.292/10

Distress zone — elevated risk

Profit MarginProfitability
-18.1%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : AJG

The strongest argument for AJG centers on Revenue Growth, Debt/Equity, Market Cap. Revenue growth of 30.9% demonstrates continued momentum. PEG of 0.72 suggests the stock is reasonably priced for its growth.

Bull Case : LIFE

The strongest argument for LIFE centers on Revenue Growth, Debt/Equity. Revenue growth of 113.4% demonstrates continued momentum.

Bear Case : AJG

The primary concerns for AJG are P/E Ratio, Return on Equity, EPS Growth.

Bear Case : LIFE

The primary concerns for LIFE are Return on Equity, EPS Growth, Altman Z-Score.

Key Dynamics to Monitor

AJG profiles as a growth stock while LIFE is a hypergrowth play — different risk/reward profiles.

LIFE is growing revenue faster at 113.4% — sustainability is the question.

LIFE generates stronger free cash flow (34M), providing more financial flexibility.

Monitor INSURANCE BROKERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AJG scores higher overall (62/100 vs 33/100) and 30.9% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arthur J Gallagher & Co

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Arthur J. Gallagher & Co. (AJG) is an American global insurance brokerage and risk management services firm headquartered in Rolling Meadows, Illinois.

Ethos Technologies Inc. Class A Common Stock

FINANCIAL SERVICES · INSURANCE BROKERS · USA

aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.

Want to dig deeper into these stocks?